Literature DB >> 25124826

Comparison of Tc-99m tetrofosmin myocardial perfusion scintigraphy and exercise F18-FDG imaging in detection of myocardial ischemia in patients with coronary artery disease.

Sasikumar Arun1, Bhagwant Rai Mittal, Anish Bhattacharya, Manoj Kumar Rohit.   

Abstract

BACKGROUND: Direct ischemia imaging with F18-FDG can potentially overcome many limitations of SPECT-MPS inherent to "cold imaging". We compared SPECT-MPS with exercise F18-FDG PET in detection of ischemia in patients with suspected CAD.
METHODS: 45 patients with clinical suspicion of CAD without the history of myocardial infarction were prospectively included. All patients underwent Tc-99m tetrofosmin SPECT-MPS and exercise F18-FDG PET imaging within 7 days of SPECT-MPS, and both modalities were compared with coronary angiography for detecting ischemia.
RESULTS: 27 patients had an abnormal coronary angiography (at least one coronary artery with stenosis >50%). Exercise F18-FDG performed better than SPECT-MPS in LAD and LCX territory with comparably good performance in RCA territory. Exercise F18-FDG performed better in single-vessel disease and equally good in multi-vessel disease compared to SPECT-MPS. Performance of exercise 18F-FDG study was significantly better than SPECT-MPS (P = .0014) in the analysis of the 81 vascular territories in the 27 patients with abnormal coronary angiography. Performance of exercise F18-FDG was significantly better than SPECT-MPS in detecting ischemia in suspected CAD patients.
CONCLUSION: Exercise F18-FDG imaging is a potentially useful ischemia imaging modality which offers the advantages of direct ischemia imaging in CAD patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25124826     DOI: 10.1007/s12350-014-9954-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  29 in total

Review 1.  Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease.

Authors:  G A Beller; B L Zaret
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

Review 2.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  J Nucl Cardiol       Date:  2002 Mar-Apr       Impact factor: 5.952

3.  Pursuit of the ideal perfusion agent.

Authors:  Barry L Zaret
Journal:  J Nucl Cardiol       Date:  2002 Mar-Apr       Impact factor: 5.952

4.  Myocardial microangiopathy associated with antiphospholipid antibodies.

Authors:  B R Lauwerys; M Lambert; J L Vanoverschelde; J P Cosyns; F A Houssiau
Journal:  Lupus       Date:  2001       Impact factor: 2.911

5.  Noninvasive regional myocardial perfusion with radioactive potassium. Study of patients at rest, with exercise and during angina pectoris.

Authors:  B L Zaret; H W Strauss; N D Martin; H P Wells; M D Flamm
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

6.  [18F]Fluorodeoxyglucose as a memory marker of transient myocardial ischaemia.

Authors:  Brian G Abbott; Yi-Hwa Liu; James A Arrighi
Journal:  Nucl Med Commun       Date:  2007-02       Impact factor: 1.690

7.  Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain.

Authors:  Y Kawai; E Tsukamoto; Y Nozaki; K Morita; M Sakurai; N Tamaki
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

Review 8.  Exercise (18)FDG imaging for the detection of CAD: What are the clinical hurdles?

Authors:  Diwakar Jain; Zuo-Xiang He; Afshin Ghanbarinia
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

9.  Direct imaging of exercise-induced myocardial ischemia with fluorine-18-labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease.

Authors:  Zuo-Xiang He; Rong-Fang Shi; Yong-Jian Wu; Yue-Qin Tian; Xiu-Jie Liu; Shi-Wen Wang; Rui Shen; Xue-Wen Qin; Run-Lin Gao; Jagat Narula; Diwakar Jain
Journal:  Circulation       Date:  2003-08-25       Impact factor: 29.690

10.  Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007.

Authors: 
Journal:  Ann ICRP       Date:  2008
View more
  4 in total

Review 1.  Review of cardiovascular imaging in the journal of nuclear cardiology in 2015. Part 1 of 2: Plaque imaging, positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-11-05       Impact factor: 5.952

2.  'Hot spot' cardiac ischemia imaging with fluorodeoxyglucose positron emission tomography.

Authors:  Marissa T Ferguson; Andrew Mallia; Kenneth Yap; Samuel Wright; Rodney J Hicks; Michael S Hofman
Journal:  J Nucl Cardiol       Date:  2016-01-11       Impact factor: 5.952

3.  Direct myocardial ischemia imaging with exercise ¹⁸FDG.

Authors:  Diwakar Jain; Zuo-Xiang He
Journal:  J Nucl Cardiol       Date:  2015-02       Impact factor: 5.952

4.  Dual-time-point myocardial 18F-FDG imaging in the detection of coronary artery disease.

Authors:  Ke-Fei Dou; Xiao-Jin Gao; Bo-Qia Xie; Yan Li; Zuo-Xiang He; Min-Fu Yang
Journal:  BMC Cardiovasc Disord       Date:  2017-05-10       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.